Drug Development
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges
| 2 min read
Industry-approved fluidic-free standard for label-free molecular interaction analysis
| 1 min read
New applications also provide a boost for the technique's possible use in subcellular characterization
| 4 min read
Demonstrating the novel technique on prexersatib, research team achieves a fully automated six-step synthesis with 65 percent isolated yield within 32 hours
| 3 min read
Detection innovation could enhance drug development and cancer research
| 2 min read
The Nucleofector™ System offers a flexible, reliable approach to transfection, including for primary cells, which are typically hard to transfect
| 2 min read
New CSD-Theory software enables organizations to incorporate and share CSP data earlier and more easily, reducing risk and shortening the time to market for small molecule drug development
| 3 min read
Scientists have now developed a machine learning method that supports the antibody optimization phase, helping to develop more effective antibody drugs
| 3 min read
Based on their analyses, researchers call for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2 to treat COVID-19 in its early stages
| 4 min read
This next-generation automated platform aims to solve the challenges commonly associated with batch production of lipid nanoparticles and liposomes for drug and vaccine development
| 2 min read
